GB1208014A - Cephalosporins - Google Patents

Cephalosporins

Info

Publication number
GB1208014A
GB1208014A GB03867/67A GB1386767A GB1208014A GB 1208014 A GB1208014 A GB 1208014A GB 03867/67 A GB03867/67 A GB 03867/67A GB 1386767 A GB1386767 A GB 1386767A GB 1208014 A GB1208014 A GB 1208014A
Authority
GB
United Kingdom
Prior art keywords
acid
chloro
chloride
prepared
cephalosporanic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB03867/67A
Inventor
Alan Gibson Long
Edward Mckenzie Wilson
William Graham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Priority to GB03867/67A priority Critical patent/GB1208014A/en
Priority to CH411968A priority patent/CH507984A/en
Priority to FR144493A priority patent/FR7572M/fr
Priority to FR1556822D priority patent/FR1556822A/fr
Priority to DE19681770031 priority patent/DE1770031A1/en
Priority to SE388168A priority patent/SE364284B/xx
Priority to NL6804139A priority patent/NL156702B/en
Priority to DK124068A priority patent/DK124265B/en
Publication of GB1208014A publication Critical patent/GB1208014A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Abstract

1,208,014. Cephalosporins. GLAXO LABORATORIES Ltd. 12 March, 1968 [23 March, 1967], No. 13867/67. Headings C2A and C2C. [Also in Division A5] The invention comprises 7 - arylglyoxamido cephalosporanic acids of Formula I wherein Ar is an aromatic group (including a heterocyclic aromatic group e.g. pyridyl or thienyl) having an atomic weight of at least 78; a salt thereof and an α - carbonyl derivative thereof e.g. oxime, methoxime, hydrazone, semicarbazone, thiosemicarbazone and isonicotinoylhydrazone. Ar may be the group where R is NH 2 , substituted NH 2 , halo, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkoxycarbonyl, NO 2 or CN, n is 1 to 4, the groups R when n is greater than 1 being the same or different. Ar may be 1 - naphthyl or 2 - phenanthryl. Typical compounds are 7 - (p - dimethylaminophenylglyoxamido) cephalosporanic acid and 7 - (p - chlorophenylglyoxamido) cephalosporanic acid. The compounds are produced by acylating 7 - amino cephalosporanic acid with an aromatic glyoxylic acid Ar.CO.CO.COOH wherein Ar has the above meaning, or a reactive derivative thereof e.g. acid halide, reactive azide, anhydride or mixed acid anhydride with e.g. butyric, valeric, isovaleric, trifluoroacetic or pivalic acids. Salts are formed with the alkali and alkaline earth metals, organic bases e.g. procaine, acids (where Ar contains a basic group) and resins e.g. a polystyrene resin containing amino, quarternary amino or sulphonic acid groups or a resin containing carboxyl groups e.g. a polyacrylic acid resin. 5 - chloro - 2 - methoxy - 4 - methylphenylglyoxylic acid is prepared by reacting 2 - chloro - 5 - methoxy toluene with ethyl oxalyl chloride in the presence of aluminium chloride, followed by treatment with hydrochloric acid and hydrolysis with NaOH to remove the ester group. m - iodophenylglyoxylic acid is prepared by nitrating acetophenone to produce m - nitroacetophenone, subjecting m - nitroacetophenone to reduction, diazotization and treatment with potassium iodide to give m - iodoacetophenone, and treating m - iodoacetophenone with KMnO 4 and KOH, followed by acidification with hydrochloric acid. 4 - chloro - 3 - nitrophenyl glyoxylic acid is produced by reacting 4 - chloro - 3 - nitrobenzaldehyde with sodium metabisulphite and sodium cyanide to give 4 - chloro - 3 - nitromandelic acid, esterifying the 4 - chloro - 3 - nitromandelic acid with CH 3 OH and H 2 SO 4 and treating the resultant methyl ester with lead tetra acetate and then with NaOH followed by acidification. o - Bromophenylglyoxylic acid is produced by the diazotization of isatin and the addition of the resultant diazonium salt to a boiling mixture of CuSO 4 , copper, NaBr, H 2 SO 4 and water. p - Formamidophenylglyoxylic acid is prepared by reducing p - nitrophenylglyoxylic acid with ferrous sulphate in aqueous NH 4 OH to give p aminophenylglyoxylic acid, which is then treated with dry formic acid and acetic anhydride. α - methoximinophenylacetyl chloride is prepared by reacting phenylglyoxylic acid with methoxyammonium chloride previously treated with potassium acetate in methanol to form α - methoximinophenylacetic acid which is then treated with thionyl chloride. The cephalosporins are active antibiotics which may be administered orally (see Division A5). Specification 1,104,937 is referred to.
GB03867/67A 1967-03-23 1967-03-23 Cephalosporins Expired GB1208014A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB03867/67A GB1208014A (en) 1967-03-23 1967-03-23 Cephalosporins
CH411968A CH507984A (en) 1967-03-23 1968-03-20 Process for the preparation of 7-acylaminocephalosporanic acids
FR144493A FR7572M (en) 1967-03-23 1968-03-20
FR1556822D FR1556822A (en) 1967-03-23 1968-03-20
DE19681770031 DE1770031A1 (en) 1967-03-23 1968-03-22 New derivatives of cephalosporin C and process for their preparation (1)
SE388168A SE364284B (en) 1967-03-23 1968-03-22
NL6804139A NL156702B (en) 1967-03-23 1968-03-22 PROCESS FOR THE PREPARATION OF A CEPHALOSPORIN DERIVATIVE AND FORMED PREPARATION WITH ANTI-BACTERIAL ACTION CONTAINING SUCH CEPHALOSPORIN DERIVATIVE.
DK124068A DK124265B (en) 1967-03-23 1968-03-22 Analogous process for the preparation of cephalosporan derivatives or α-carbonyl derivatives or salts thereof or of the α-carbonyl derivatives.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB03867/67A GB1208014A (en) 1967-03-23 1967-03-23 Cephalosporins

Publications (1)

Publication Number Publication Date
GB1208014A true GB1208014A (en) 1970-10-07

Family

ID=10030837

Family Applications (1)

Application Number Title Priority Date Filing Date
GB03867/67A Expired GB1208014A (en) 1967-03-23 1967-03-23 Cephalosporins

Country Status (7)

Country Link
CH (1) CH507984A (en)
DE (1) DE1770031A1 (en)
DK (1) DK124265B (en)
FR (2) FR1556822A (en)
GB (1) GB1208014A (en)
NL (1) NL156702B (en)
SE (1) SE364284B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2223375A1 (en) * 1971-05-14 1972-11-23 Glaxo Lab Ltd Antibiotics and their method of manufacture
JPS52108997A (en) * 1976-03-09 1977-09-12 Fujisawa Pharmaceut Co Ltd 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and their salts and their preparation
JPS5248996B1 (en) * 1971-01-29 1977-12-14 Glaxo Lab Ltd
US8993574B2 (en) 2008-04-24 2015-03-31 F2G Ltd Pyrrole antifungal agents
US10201524B2 (en) 2014-11-21 2019-02-12 F2G Limited Antifungal agents
US10973821B2 (en) 2016-05-25 2021-04-13 F2G Limited Pharmaceutical formulation
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1389194A (en) * 1971-01-29 1975-04-03 Glaxo Lab Ltd Antibiotics
IE36041B1 (en) * 1971-01-29 1976-08-04 Glaxo Lab Ltd Improvements in or relating to antibiotics
DE2818263A1 (en) * 1978-04-26 1979-11-08 Bayer Ag BETA LACTAMANTIBIOTICS
IT1211080B (en) * 1981-07-21 1989-09-29 Craf Sud BIOLOGICALLY ACTIVE HYDRAZONOCEFEM.
GB8810393D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5248996B1 (en) * 1971-01-29 1977-12-14 Glaxo Lab Ltd
DE2223375A1 (en) * 1971-05-14 1972-11-23 Glaxo Lab Ltd Antibiotics and their method of manufacture
DE2265234A1 (en) * 1971-05-14 1976-12-30 Glaxo Lab Ltd INTERMEDIATE PRODUCTS FOR ANTIBIOTICS AND PROCESS FOR THEIR MANUFACTURING
JPS531280B1 (en) * 1971-05-14 1978-01-17
JPS52108997A (en) * 1976-03-09 1977-09-12 Fujisawa Pharmaceut Co Ltd 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and their salts and their preparation
JPS633867B2 (en) * 1976-03-09 1988-01-26 Fujisawa Pharmaceutical Co
US8993574B2 (en) 2008-04-24 2015-03-31 F2G Ltd Pyrrole antifungal agents
US9452168B2 (en) 2008-04-24 2016-09-27 F2G Ltd Pyrrole antifungal agents
US10201524B2 (en) 2014-11-21 2019-02-12 F2G Limited Antifungal agents
US10596150B2 (en) 2014-11-21 2020-03-24 F2G Limited Antifungal agents
US11065228B2 (en) 2014-11-21 2021-07-20 F2G Limited Antifungal agents
US10973821B2 (en) 2016-05-25 2021-04-13 F2G Limited Pharmaceutical formulation
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection

Also Published As

Publication number Publication date
FR7572M (en) 1970-01-05
DK124265B (en) 1972-10-02
CH507984A (en) 1971-05-31
SE364284B (en) 1974-02-18
NL156702B (en) 1978-05-16
NL6804139A (en) 1968-09-24
DE1770031A1 (en) 1971-09-16
FR1556822A (en) 1969-02-07

Similar Documents

Publication Publication Date Title
GB1208014A (en) Cephalosporins
GB1283225A (en) Derivatives of cyclopropane carboxylic acid and process for their preparation
GB1456221A (en) 3-hydroxy cephalosporins their ether derivatives and methods for their preparation
ES371426A1 (en) Synthesis of arylchlorocarbonyl ketenes
GB1499026A (en) Adriamycin esters
GB1432649A (en)
GB980777A (en) ª‡-amino-substituted penicillins
GB1282493A (en) A process for the preparation of dithioesters
IE34427L (en) Alkenoic acid derivatives.
GB1306404A (en) Indenopyridine derivatives
GB1042901A (en) Production of 4-nitro-5-hydroxypyridazones-(6)
GB1054209A (en)
GB986554A (en) Penicillins
GB1382785A (en) 1,4-ethano-2,3-dihydroquinoline derivatives
GB1265800A (en)
JPS5549384A (en) Novel antibacterial compound
JPS5798258A (en) Beta-lactamase inhibitor composition
GB1365954A (en) Process for acetylation
GB1317257A (en) 4-thiazole carboxyldehyde derivatives
GB1394366A (en) 2-aminothiophene derivatives
GB934428A (en)
JPS5527111A (en) Preparation of cephapirin
JPS5484590A (en) 2-methyl-7-substituted-2 or 3-cephem-4-carboxylic acid, its salt, and their preparation
GB1377248A (en) Furan derivatives
GB873244A (en) Improvements in or relating to penicillins

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee